Biotechnologist

Research Scholar

22/09/2021 – 21/03/2024 University of Trento, Department of Cellular, Computational and Integrative Biology (CIBIO) 
Master’s Degree in Cellular and Molecular Biotechnologies (LM-9)
Thesis: Unravelling the impact of p53 isoforms in multiple myeloma 

11/09/2018 – 19/09/2021 University of Trento, Department of Cellular, Computational and Integrative Biology (CIBIO) 
BSc Degree in Biomolecular Sciences and Technology (L-2)
Thesis: Base editing of FLT3 to treat acute myeloid leukemia by anti-FLT3 CAR T immunotherapy

11/04/2024 – 31/12/2024 CIBIO – Center For Integrative Biology, Via Sommarive 9, 38123,Trento, Italy
Fellowship
Aim: characterization of the biological mechanisms activated by proton therapy in cardiac tissue.

06/03/2023 – 26/02/2024 CIBIO – Center For Integrative Biology, Via Sommarive 9, 38123, Trento, Italy
Internship
Thesis: Unravelling the impact of p53 isoforms in multiple myeloma

09/10/2020 – 14/03/2021 Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, 02119, Boston, United States
Internship
Thesis: Base editing of FLT3 to treat acute myeloid leukemia by anti-FLT3 CAR T immunotherapy

Mother tongue: Italian
Other language(s): English (C1)

Microsoft Office, Microsoft Word, Microsoft Powerpoint, Microsoft Excel Outlook, Power Point, Programming languages (Python and R program), GaphPad Prism, PrimerBlast, Benchling, Pubmed.

Role of P53 alterations for the prediction of response to immunotherapy in advanced carcinoma non-small cell lung cancer patients
Poster presented at: 19th International p53 Workshop; 2024 May 13-16; Trieste, IT
Moretta et al.

Role of P53 alterations for the prediction of response to immunotherapy in advanced carcinoma non-small cell lung cancer patients 
Poster presented at: Annual Scientific Retreat at San Martino Hospital; 2023 Nov 23-24; Genova, IT
Marcaccini et al.